Advanced Nasopharyngeal Carcinoma Clinical Trials

1 recruiting

Advanced Nasopharyngeal Carcinoma Trials at a Glance

7 actively recruiting trials for advanced nasopharyngeal carcinoma are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Guangzhou, Hangzhou, and Guangzhou. Lead sponsors running advanced nasopharyngeal carcinoma studies include First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, and Sun Yat-sen University.

Browse advanced nasopharyngeal carcinoma trials by phase

Treatments under study

About Advanced Nasopharyngeal Carcinoma Clinical Trials

Looking for clinical trials for Advanced Nasopharyngeal Carcinoma? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Nasopharyngeal Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Nasopharyngeal Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma
Yonsei University57 enrolled1 locationNCT04910347
Recruiting
Phase 2

Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC

ImmunotherapyInduction TherapyLocally Advanced Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT07085234
Recruiting
Not Applicable

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University190 enrolled20 locationsNCT05892354
Recruiting
Phase 3

Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University474 enrolled1 locationNCT05860868
Recruiting
Phase 2

SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC

Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital37 enrolled1 locationNCT05652192
Recruiting
Phase 2

Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

PD-L1Locally Advanced Nasopharyngeal CarcinomaInduction Chemotherapy+1 more
Sun Yat-sen University36 enrolled1 locationNCT05397769
Recruiting
Phase 3

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University447 enrolled1 locationNCT05062005